Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03351296
Title Two Chemotherapy Regimens Plus or Minus Bevacizumab (BETTER 2)
Acronym BETTER2
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gustave Roussy, Cancer Campus, Grand Paris
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Centre Antoine Lacassagne Nice Alpes-Maritimes 06189 France Details
CHU de Caen Caen Calvados 14033 France Details
CHU de Dijon Dijon Côte d'Or 21000 France Details
Hôpital Haut-Lévêque Pessac Gironde 33600 France Details
IUCT - Hôpital Rangueil Toulouse Haute-Garonne 31400 France Details
Hôpital Beaujon Clichy Hauts-de-Seine 92110 France Details
ICM Val d'Aurelle Montpellier Hérault 34298 France Details
Hôpital Trousseau CHU Tours Chambray-lès-Tours Indre-et-Loire 37170 France Details
Institut de Cancérologie de l'Ouest site René Gauducheau Saint-Herblain Loire-Atlantique 44800 France Details
CHR d'Orléans Orléans Loiret 45067 France Details
CHU Angers Angers Maine-et-Loire 49100 France Details
Hôpital Haut-Lévêque Reims Marne 51092 France Details
Institut de Cancérologie de Lorraine Vandœuvre-lès-Nancy Meurthe-et-Moselle 54519 France Details
Hôpital Edouard Herriot Lyon Rhône 69437 France Details
Gustave Roussy Villejuif Val De Marne 94805 France Details
Hôpital Croix St Simon Paris 75012 France Details
Hôpital Saint-Antoine Paris 75012 France Details
Hôpital Cochin Paris 75014 France Details
Hôpital Européen Georges Pompidou Paris 75015 France Details
Centre Eugène Marquis Rennes Île-et-Vilaine 35000 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field